The EMA has updated the QRD Product Information template (version 10.0) as part of their measures to protect patients from falsified medicines. A unique identifier and anti-tampering device will now be required on the packaging of the majority of prescription medicines and some non-prescription medicines.

The links to this latest news from the EMA and the updated template are provided.

The EUDRAC procedure for implementing the translation and linguistic review of Product Information required following most CAP procedures involving the Product Information is available here.